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Table 1 Activity of the naphthoquinones on bloodstream
trypomastigotes of T. cruzi at 37°C
Cpd Nomenclaturea IC50/24 h (μM)
NQ1 1,4-Naphthoquinone 0.79 ± 0.02
NQ2 2-Methyl-1,4-naphthoquinone (menadione) 6.04 ± 0.35
NQ3 2-Hydroxy-1,4-naphthoquinone (lawsone) 563.18 ± 83.28
NQ4 2-Acetoxy-1,4-naphthoquinone 63.02 ± 5.8
NQ5 2-Bromo-1,4- naphthoquinone 1.37 ± 0.03
NQ6 2,3-Dichloro-1,4- naphthoquinone (dichlone) 2.17 ± 0.29
NQ7 5-Hydroxy-1,4-naphthoquinone (juglone) 6.51 ± 0.48
NQ8 5-Acetoxy-1,4- naphthoquinone 0.16 ± 0.01
NQ9 5-Methoxy-1,4-naphthoquinone 1.02 ± 0.29
NQ10 2-Bromo-5-hydroxy-1,4-naphthoquinone 2.15 ± 0.22
NQ11 2-Bromo-5-acetoxy-1,4-naphthoquinone 2.43 ± 0.50
NQ12 2-Bromo-5-methoxy-1,4-naphthoquinone 1.25 ± 0.26
NQ13 3-Bromo-5-hydroxy-1,4-naphthoquinone 2.52 ± 0.37
NQ14 3-Bromo-5-acetoxy-1,4-naphthoquinone 0.85 ± 0.08




Bz Benznidazole 26.0 ± 4.0
aThe bromo derivatives (NQ10-NQ15) are named based on the core juglone
(NQ7) system.
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Chagas’ disease (CD), caused by Trypanosoma cruzi,
affects approximately eight million individuals in Latin
America [1,2] and is emerging in non-endemic areas due
to the globalization of immigration and non-vector
transmission routes [3]. The available therapy for CD is
based on two nitroheterocycles, benznidazole (Bz) and
nifurtimox, and was developed more than four decades
ago. Both nitroheterocycles are far from ideal due to
substantial secondary side effects, limited efficacy against
different parasite isolates, the need for long-term therapy
and their well-known poor activity in the late chronic
phase. These drawbacks justify the urgent need to iden-
tify better drugs to treat chagasic patients [4].
Naphthoquinones account for the largest number of
natural naphthalenes, holding a number of different sub-
stituents with a variety of structural motifs. They act as
vital links in the electron transport chains in metabolic
pathways and participate in multiple biological oxidative
processes [5]. Quinone-containing plants have been used
in diverse cultures as dyes, cosmetics, and food and, es-
pecially among Indian populations, for the treatment of
different diseases [6,7]. Naphthoquinones are considered
privileged structures in medicinal chemistry due to their
structural properties and biological activities [8], especially
against tumor cells and pathogenic protozoa [9,10]. Two
major mechanisms of quinone cytotoxicity have been pro-
posed: stimulation of oxidative stress and alkylation of cel-
lular nucleophiles, which are the mechanisms of action
common to a large range of biomolecules [11].
Among the simple hydroxylated naphthoquinones,
juglone (5-hydroxy-1,4-naphthoquinone), isolated from
walnut trees (Juglandaceae), has shown a variety of
biological effects, including microbicidal [12], anti-
inflammatory [13] and antitumoral [14,15] effects that
are associated with the induction of oxidative stress. As
part of our continuing program of screening natural and
synthetic quinones for trypanocidal activity, in the present
work we investigated the activity and mode of action of
naphthoquinones and specific juglone derivatives.
Results
Activity on bloodstream trypomastigotes
In the present work, we initially evaluated the efficacy of
sixteen 1,4-naphthoquinones (1,4-NQs) against the infect-
ive bloodstream trypomastigote forms of T. cruzi at 37°C
in Dulbecco’s modified Eagle’s medium (Sigma-Aldrich)
plus 10% fetal calf serum (DMES) (Table 1). The prototype,
1,4-naphthoquinone (NQ1), was compared with other de-
rivatives that were substituted at C-2 with methyl (NQ2),
hydroxyl (NQ3), acetoxy (NQ4), and bromo (NQ5) groups
or that were disubstituted at C-2 and C-3, such as 2,3-
dichoro-1,4-naphthoquinone (NQ6). In addition, juglone
(NQ7) and its derivatives, including those brominated atC-2 (NQ10 to NQ12) or C-3 (NQ13 to NQ15) and 2-
methyl-5-hydroxy-1,4-naphthoquinone (NQ16), were also
examined. Fourteen compounds displayed an IC50 in the
range of 0.16 to 6.51 μM, demonstrating higher activity
than Bz (26.0 μM), and the other two tested compounds
were less active: NQ3 (563.18 μM) and NQ4 (63.02 μM)
(Table 1).
Among the most active compounds on trypomastigotes
at 37°C, four were selected for further studies: the proto-
type naphthoquinone (NQ1) and three juglone derivatives
(NQ8, NQ9 and NQ12) (Figure 1). Interestingly, their ac-
tivity against trypomastigotes was not decreased when the
experiments were performed at 4°C in culture medium,
but at this lower temperature in the presence of whole
blood, IC50 values higher than 500 μM were obtained
(data not shown).
Activity on the proliferative forms of T. cruzi and toxicity
to mammalian cells
The selected compounds (NQ1, NQ8, NQ9 and NQ12)
were also assayed using the proliferative forms of T.
cruzi: axenic epimastigotes and intracellular amastigotes.
A dose-dependent effect on epimastigotes was observed,
leading to the IC50 values for proliferation inhibition for
1 to 4 days of treatment displayed in Table 2. Comparing
the four NQs, the prototype unsubstituted quinone NQ1
was the most active against epimastigotes.
Table 2 IC50 values (μM) of the naphthoquinones on the
proliferation of T. cruzi epimastigotes
Cpd 1 day 2 days 3 days 4 days
NQ1 0.30 ± 0.08a 0.24 ± 0.03 0.26 ± 0.04 0.26 ± 0.05
NQ8 0.76 ± 0.12 0.35 ± 0.09 0.24 ± 0.10 0.36 ± 0.07
NQ9 2.62 ± 0.38 1.05 ± 0.19 1.08 ± 0.17 1.27 ± 0.21
NQ12 0.55 ± 0.01 0.48 ± 0.06 0.45 ± 0.05 0.44 ± 0.11
aMean ± standard deviation of at least three independent experiments.
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tures of both peritoneal macrophages and HMCs after
the removal of non-interiorized parasites. For both host
cells the inhibitory effect on the percent infection was in
the range of 0.5 to 5.0 μM. Surprisingly, NQ8 and NQ9
caused about a 2.5-fold decrease of infection. For both
host cells, the IC50 values after 48 h of treatment used to
calculate the endocytic index are displayed in Table 3.
NQ8 was the most active compound. Non-infected mac-
rophages and HMCs treated with the compounds for
2 days were tested with the MTT assay to evaluate their
toxicity to mammalian cells. For HMCs, the LC50 values
were 8 μM for NQ1 and NQ12 and 10 μM for NQ8;
NQ9 was the least toxic quinone with values higher than
10 μM. The LC50 was higher than 10 μM in macro-
phages for all four compounds.
Ultrastructural analysis
Transmission electron microscopy showed that treat-
ment with the NQs induced important alterations in the
mitochondrion of the epimastigotes, leading to swelling
and the appearance of membranous structures in the or-
ganelle matrix (Figures 2, 3, 4 and 5). Autophagic fea-
tures, such as atypical cytosolic membranous structuresFigure 1 Chemical structures of the studied naphthoquinones.(Figures 3, 4, 5) and the appearance of endoplasmic
reticulum surrounding reservosomes (Figures 2 and 5),
were detected in treated parasites. The naphthoquinones
also led to intense cytosolic vacuolization (Figures 4 and 5),
the formation of blebs in the flagellar region (Figures 2, 3
and 5) and the induction of loss of the electron-density of
the cytosol (washed out aspect) (Figures 3 and 5). The scan-
ning electron microscopy technique demonstrated no im-
portant morphological alterations in treated epimastigotes
(data not shown).
Flow cytometry analysis
This technique was employed to evaluate the mitochon-
drial membrane potential (ΔΨm) dissipation by labeling
Table 3 IC50 values (μM) of the naphthoquinones on
intracellular amastigotes of T. cruzi
Cpd HMC Macrophages
NQ1 2.81 ± 0.43a,b 3.65 ± 0.71
NQ8 1.53 ± 0.11 1.49 ± 0.01
NQ9 2.48 ± 0.39 1.63 ± 0.18
NQ12 9.83 ± 2.64 2.51 ± 0.71
aThe IC50 was calculated for the endocytic index (number of parasites/100 host
cells) after two days of treatment.
bMean ± standard deviation of at least three independent experiments.
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presence of 10 μM FCCP. The four NQs, at IC50 levels,
induced a significant decrease in the TMRE fluores-
cence, denoted in Table 4 by the reduction of the IV
values (see Methods) from −0.22 to −0.53. NQ8 at the
concentration of 8 μM presented the most remarkable
reduction in the fluorescence intensity of the marker
and totally disrupted the ΔΨm of about 20% of the para-
sites (Table 4). On the other hand, treatment with NQ1,
NQ9 or NQ12 induced no alteration in the percentage
of TMRE + epimastigotes, a finding that was quite simi-
lar to that observed in control parasites. ROS produc-
tion was assessed by DHE labeling and incubation with
AA, a potent ROS inducer. Only treatment at the IC50
of NQ8 led to a discrete increase in the percentage of
DHE + parasites (Table 4). The other three NQs yielded
the same labeling pattern as the untreated cells at every
dose tested.Discussion
Initially, the sixteen derivatives were assayed against
bloodstream forms of T. cruzi at 37°C (Table 1). The ac-
tivity of NQ1 was surprising because this compound is
the nonsubstituted 1,4-naphthoquinone. The introduc-
tion of a hydroxyl at C5 (NQ7, juglone) is detrimental to
the trypanocidal activity, which is decreased 8× in com-
parison with the parent quinone. Among the three sim-
ple juglone derivatives, the substitution of a hydroxyl by
an acetoxy or methoxy group leads to higher biological
activity. The O-methylated (NQ9) and the O-acetylated
(NQ8) juglone derivatives were 6.4× and 40×, respect-
ively, more active than juglone (NQ7) itself. Among the
2- and 3-bromojuglone derivatives (NQ10 to NQ15), re-
gardless of the substituent, roughly the same efficacy
was observed (IC50 between 1.2 and 2.5 μM), with the
exception of NQ14, which displayed trypanocidal activity
similar to that of nonsubstituted NQ1. Moreover, NQ12
and NQ15 are very similar and, in both cases, are
slightly less effective than the parent methyl ether NQ9.
This trend is also valid among the 5-hydroxy derivatives.
Thus, NQ10 and NQ13 had similar activity but showed
3-fold higher activity than juglone itself (NQ7).The effect of the juglone derivatives was previously in-
vestigated on Aedes aegypti, the vector of dengue, and
on adult Biomphalaria glabrata snails [16]. Concerning
the larvicidal activity, NQ10, NQ11 and NQ13 were the
most active, with IC50 values of about 4 μM. With
respect to their molluscidal effects, NQ11, NQ12, NQ14
and NQ15 had ranges of activity between 1.8 and
3.2 μM. Cytotoxic assays using four human cancer cell
lines revealed that NQ9 was the most active, with IC50/
72 h values ranging from 1.7 to 4.7 μM, whereas for
juglone (NQ7), this range was from 7.6 to over 28.7 μM
[14]. The mechanism underlying the cytotoxicity of NQ9
to HL-60 cells involved the activation of caspases leading
to an induction of apoptosis independent of mitochon-
dria depolarization [14].
Leaving aside the juglone derivatives, and with the ex-
ceptions of NQ3, previously shown by us as inactive
against T. cruzi in other experimental conditions [17],
and of NQ4, all the compounds displayed IC50 values in
the range of 1.37 (NQ5) to 6.04 (NQ2) μM, correspond-
ing to a higher activity in comparison with the standard
drug benznidazole, which has an IC50 value of 26.0 ±
4.0 μM. In a study with Bolivian medicinal plants, Fournet
and colleagues [18,19] reported the potent effect of NQ16
(plumbagin), isolated from Pera benensis, against T. cruzi
and different species of Leishmania.
The four compounds that were most active on blood-
stream forms at 37°C were assayed also at 4°C: in the ab-
sence of blood, the lytic effect on trypomastigotes was
not decreased, while in the presence of whole blood,
IC50 values higher than 500 μM were obtained. These
results are consistent with previous reports on the lit-
erature regarding the inactivation of the trypanocidal
activity of quinones in the presence of blood compo-
nents [17,20]. Comparing the susceptibility of the differ-
ent developmental forms of T. cruzi to the compounds,
it was observed that bloodstream trypomastigotes were
more susceptible to NQ8, whereas epimastigotes were
more susceptible to NQ1. Intracellular amastigotes from
heart muscle cells or peritoneal macrophages were at
least 2-fold more resistant to treatment with NQ1, NQ8
and NQ12.
For the subsequent investigation of the mode of action
of the four selected NQs, electron microscopy and flow
cytometry assays with epimastigotes were employed,
never exceeding the respective IC50 values. Treatment
with these compounds led to remarkable ultrastructural
alterations, especially in the mitochondrion. The ap-
pearance of different morphological features suggestive
of autophagic activity and the interference in flagellar
membrane fluidity with bleb formation were also recur-
rent alterations.
Mitochondrial susceptibility to treatment with naph-
thoquinones and its derivatives has been extensively
Figure 2 Transmission electron microscopy analysis of T. cruzi epimastigotes treated with NQ1. (A) Untreated epimastigote showing
normal ultrastructural aspect and presenting typical morphologies of the mitochondrion (M), kinetoplast (K), flagellum (F), nucleus (N), Golgi (G),
reservosome (R) and cytostome (Cy). (B-E) The concentration of 0.3 μM NQ1 led to swelling in the mitochondrion (*), the formation of abnormal
cytosolic membranous structures (white arrowheads) and the appearance of endoplasmic reticulum surrounding reservosomes (white arrows).
Blebs (thick black arrows) was formed in the flagellar membrane of treated parasites. Bars = 500 nm (A, B, E) and 200 nm (C, D).
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sites exhibit unique structural and functional features
that are remarkably distinct from mammalian counter-
parts. The absence of efficient mechanisms for ROS de-
toxification in these parasites make the mitochondrion agood target for drug intervention [29], and functional
evaluation of the organelle by ΔΨm measurement
represents an important step for the examination of the
mechanism of action of novel drugs [22-24,28]. Here, we
assessed ΔΨm by TMRE labeling in epimastigotes
Figure 3 Transmission electron microscopy analysis of T. cruzi epimastigotes treated with NQ8. (A-D) Treatment with 0.8 μM NQ8 led to
swelling in the mitochondrion (*) and the appearance of membranous structures inside the organelle (black arrows). The formation of atypical
cytosolic membranous structures was also observed (white arrowheads) near to the washed out aspect of cytosol (black star). Blebs containing
electron-dense material (thick black arrows) were found close to the flagellar pocket. Bars = 500 nm (A-C) and 200 nm (D).
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ionophore works as an uncoupling agent that impairs
ATP synthesis by dissipating the hydrogen ion gradient
and consequently stopping oxidative phosphorylation
[30]. Flow cytometry revealed a decrease in the mito-
chondrial potential after incubation with the four NQs
at their IC50 values, and in the case of NQ8, even at a
concentration 4-fold lower (Table 4). Another parameter
analyzed was the percentage of TMRE + parasites. We
standardized the negative populations by the addition of
10 μM FCCP, which totally dissipated the ΔΨm in
epimastigotes (± 4% TMRE + cells). Interestingly, a re-
duction of about 20% in the TMRE + population was
also observed in NQ8-treated parasites at the IC50. Such
a decrease indicates that this naphthoquinone induces
the appearance of a sub-population of parasites with
metabolically inactive mitochondria.
Previous reports on the effects of several natural
quinones, such as lapachol and β-lapachone, against T.cruzi have reported the involvement of free radicals in
the trypanocidal activity [9,31], making the reduction of
NQs by parasitic flavoenzymes a promising strategy for
the development of trypanocidal drugs [32]. Mechanis-
tically, it was reasonable to postulate that the collapse of
the ΔΨm was mediated by ROS generation in the treated
parasites. In this context, the fluorescent probe DHE was
used for intracellular ROS detection, and AA was added
as a positive control because it inhibits the electron flow
through the electron transport chain, leading to the accu-
mulation of superoxide [33]. Among the four NQs tested,
only NQ8 led to a discrete increase in the percentage of
DHE + epimastigotes, giving addition evidence for the
strong effect of this quinone on the parasite ΔΨm. Indeed,
the pool of anti-oxidant defenses in epimastigotes that in-
cludes trypanothione, tryparedoxin peroxidase and other
redox enzymes leads to a protective effect in this parasite
stage, as previously described [34]. Thus, one plausible
hypothesis to explain the absence of oxidative stress
Figure 4 Transmission electron microscopy analysis of T. cruzi epimastigotes treated with NQ9. (A-C) This naphthoquinone (2.6 μM)
induced morphological alterations in the mitochondrion, including swelling (*) and the formation of membranous structures (black arrows) inside
the organelle. Parasites treated with NQ9 also presented atypical cytosolic membranous structures (white arrowheads) and intense cytosolic
vacuolization (V). Bars = 500 nm.
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of more than one mechanism of action involved in the
trypanocidal activity of these compounds, leaving ROS
generation suppressed by the detoxification system of
the parasite. Possibly, the strong redox effect of NQ8
could be associated to the presence of the acetyl group
in its structure facilitating quinone reduction, as previ-
ously demonstrated by electrochemical analysis [35].
Further experiments using different biochemical and
molecular approaches must be performed to better
characterize ROS participation in the mechanism of
action of these compounds.
Electron microscopy evidence of induction of the au-
tophagic pathway by naphthoquinones and their deriva-
tives has also been previously reported [24-26,28]. The
presence of large profiles of endoplasmic reticulum
surrounding different cellular structures, such as lipid
droplets and organelles, and the appearance of bizarre
membranous structures with a myelin-like aspect are themost common characteristics. The autophagic process rep-
resents a fundamental constitutive pathway in eukaryotic
cells that is responsible for remodeling cellular structures
and maintaining homeostasis. In trypanosomatids, other
roles for autophagy have been proposed, including in the
parasite’s differentiation [36]. In a great variety of cell
models, the loss of the balance between anabolic and cata-
bolic processes leads to non-apoptotic death [37]. In the
last decade, it has been demonstrated that the induction of
autophagy in T. cruzi trypanosomatids is triggered by sev-
eral classes of drugs, in particular naphthoquinones and
their derivatives [25,26,38]. Our transmission electron mi-
croscopy analysis suggested the involvement of endoplas-
mic reticulum and cytosolic membranous structures in
pre-autophagosomal formation, as previously postulated by
Yotimitsu & Klionsky [39].
Another ultrastructural alteration observed after the
treatment with NQs was the development of blebs in the
flagellar membrane, which was also previously reported
Figure 5 Transmission electron microscopy analysis of T. cruzi epimastigotes treated with NQ12. (A-E) Parasites treated with 0.5 μM
showed a strong mitochondrial swelling (*) with membranous structures in the organelle matrix (black arrows), the formation of flagellar blebs
(thick black arrows) and the appearance of endoplasmic reticulum in close contact with the reservosome membranes (white arrows). An intense
vacuolization (V) and washed out aspect of the cytosol (black star) were also detected after treatment with NQ12. Bars = 500 nm (A, C-E) and
200 nm (B).
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and is commonly associated with apoptosis-like death in
different cells [40].
Conclusion
Although the autophagic phenotype was the most fre-
quently observed ultrastructural alteration in treated
epimastigotes and bleb formation was the unique char-
acteristic of an apoptosis-like process, a hypothesis that
there is interplay between the distinct death pathways
through a cross-talk signaling mechanism could not be
discarded. Similar mechanisms have been demonstrated
for other eukaryotic cells in the literature [41]. Especially
in T. cruzi, the processes of death regulation are poorly
understood and deserve further studies aimed at the de-
velopment of new therapeutic agents.Methods
Compounds
The naphthoquinone NQ1 (1,4-naphthoquinone) was
purchased from Fluka (Sigma-Aldrich Chemical Co., St.
Louis, USA), NQ2 (menadione) and NQ5 were pur-
chased from Sigma-Aldrich, and NQ3 (lawsone) and
NQ6 (dichlone) were purchased from Acros Organic
(Geel, Belgium). Compound NQ4 was prepared by
standard acetylation of NQ3 [14]. All the juglone deriva-
tives (NQ7 to NQ15) were prepared according to methods
described in the literature [14]. Juglone (NQ7) is a com-
mercial material and, when needed on a large scale, was
prepared according to the method by Tietze et al. [42]
and purified by flash chromatography [14,43,44]. Acetyl-
ation of juglone under standard conditions yielded
juglone acetate (5-acetoxy-1,4-naphthoquinone, NQ8)
Table 4 Flow cytometry analysis of ΔΨm and ROS
production in T. cruzi epimastigotes
Cpd TMRE DHE
% cells+ IVa % cells+
- 97.9 ± 1.8b 0.00 3.9 ± 1.8
- + 10 μM FCCP 3.4 ± 1.5 −0.70* - c
- + 22 μM AA - - 71.8 ± 14.5
NQ1 0.1 μM 98.6 ± 1.7 0.04 6.4 ± 3.3
0.2 μM 98.3 ± 1.5 −0.07 4.7 ± 2.2
0.3 μM 96.1 ± 4.1 −0.22* 4.8 ± 2.7
NQ8 0.2 μM 97.4 ± 3.1 −0.18* 2.1 ± 0.8
0.4 μM 93.4 ± 3.1 −0.33* 2.9 ± 1.5
0.8 μM 76.7 ± 14.4 −0.53* 26.1* ± 9.9
NQ9 0.6 μM 98.5 ± 0.9 0.09 5.9 ± 2.0
1.3 μM 96.0 ± 5.1 0.04 5.0 ± 2.7
2.6 μM 92.2 ± 7.8 −0.27* 7.5 ± 4.7
NQ12 0.1 μM 98.2 ± 1.9 0.08 6.3 ± 2.7
0.2 μM 97.1 ± 3.8 0.05 5.4 ± 3.6
0.5 μM 97.7 ± 1.3 −0.22* 7.2 ± 3.8
aIV = (MT – MC)/MC, where MT corresponds to the marker median
fluorescence for treated parasites, and MC corresponds to that of control
parasites. Negative IV values correspond to depolarization of the
mitochondrial membrane.
bMean ± standard deviation of 4 independent experiments.
cNot determined.
Asterisks indicate significant differences in relation to the control group
(* p ≤ 0.002).
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naphthoquinone) was prepared by the methylation of
NQ7 using methyl iodide and silver (I) oxide [42]. For
the 2-bromojuglone derivatives, NQ10 was prepared
according to Grunwell et al. [46] by oxidative bromina-
tion of 1,5-diacetoxynaphthalene. Starting with NQ10,
we obtained NQ11 by standard acetylation and NQ12
by methoxylation [47]. The 3-bromojuglone derivatives
were prepared by selective bromination of NQ7
according to Brimble & Brenstrum [48], which yielded
NQ13 as the major isomer. From this derivative, either
by standard acetylation or methylation, NQ14 [47] and
NQ15 [49], respectively, were obtained. NQ16, which
combines the structural features of NQ2 and NQ7, was
purchased from Sigma-Aldrich (Figure 1).
Stock solutions of the compounds were prepared in
dimethylsulfoxide (DMSO), with the final concentration
of the latter in the experiments never exceeding 0.1%.
Preliminary experiments showed that at concentrations
of up to 0.5%, DMSO has no deleterious effect on the
parasites [50].
Animals
Albino Swiss mice were employed for the trypo-
mastigotes and host cells obtention. This study is inaccordance to the guidelines of the Colégio Brasileiro de
Experimentação Animal (COBEA) and was performed in
biosafety conditions. All the procedures in animal ex-
perimentation were approved by the Comissão de Ética
em Experimentação Animal (CEUA/Fiocruz), license
LW 16/13.
Parasites
All experiments were performed with the Y strain of T.
cruzi. Epimastigote forms were maintained axenically at
28°C with weekly transfers in LIT medium and harvested
during the exponential phase of growth. Bloodstream
trypomastigotes were obtained from infected mice at the
peak of parasitemia by differential centrifugation.
Effect on bloodstream trypomastigotes
The parasites were resuspended to a concentration of
10×106 cells/mL in DMES medium. This suspension
(100 μL) was added to the same volume of each of the
sixteen naphthoquinones (NQs), which had been previ-
ously prepared at twice the desired final concentrations.
The incubation was performed in 96-well microplates
(Nunc Inc., Rochester, USA) at 4°C or 37°C for 24 h at con-
centrations in the range of 0.06 to 1000 μM. Benznidazole
(Laboratório Farmacêutico do Estado de Pernambuco,
Brazil) the standard drug for treatment of chagasic patients
was used as control. For experiments performed in the
presence of 100% blood, the parasites were resuspended in
mouse blood to a concentration of 5×106 cells/mL, and
196 μL of the suspension was added to each well to-
gether with 4 μL of the NQs (0.06 to 1000 μM), which
had been selected on the basis of the results of previous
experiment and had been prepared at a concentration
50 times higher than the final concentration desired.
Cell counts were performed in a Neubauer chamber,
and the activity of the compounds corresponding to the
concentration that led to 50% lysis of the parasites was
expressed as the IC50/1 day.
Effect on epimastigotes
The parasites were resuspended in LIT medium to a
parasite concentration of 10 × 106 cells/mL. This sus-
pension was added to the same volume of the NQs
(NQ1, NQ8, NQ9 and NQ12) at concentrations in the
range of 0.06 to 10 μM and then incubated at 28°C in
24-well plates (Nunc Inc.). Cell counts were performed
daily (from 1 to 4 days) in a Neubauer chamber, and the
activity of the compounds was expressed as IC50, which
corresponds to the concentration that leads to 50% pro-
liferation inhibition.
Effect on intracellular amastigotes
Peritoneal macrophages were obtained from mice and
plated in 24-well plates (3 × 105 cells/well) (Nunc Inc.,
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trypomastigotes (10:1 parasite:host cell) in DMES medium.
After 3 h of incubation, the cultures were washed to re-
move non-internalized parasites, and the selected NQs
were added at final concentrations ranging from 0.5 to
20 μM. Alternatively, primary cultures of mouse embryo
heart muscle cells (HMCs) [51] were used. Briefly, the
hearts of 18-day-old mouse embryos were fragmented and
dissociated with trypsin and collagenase in phosphate
buffered saline (PBS), pH 7.2. Thereafter, the cells were
resuspended in Dulbecco’s modified Eagle’s medium
supplemented with horse and fetal calf sera, chicken em-
bryo extract, CaCl2 and L-glutamine; then, the cells were
plated onto gelatin-coated glass coverslips (105 cells/well)
and maintained at 37°C in 5% CO2 atmosphere. The
HMCs were plated onto gelatine-coated glass coverslips in
24-well plates (105 cells/well) and infected at a 10:1 para-
site:host cell ratio after 24 h. Afterwards the cultures were
washed, and the NQs (0.5 to 20 μM) were added. At speci-
fied intervals, the cultures were fixed in Bouin’s solution,
stained with Giemsa and counted to assess the following
parameters: percentage of cells infected, number of par-
asites/infected cell and the endocytic index (EI), which
refers to the number of parasites/100 cells [52]. The
IC50 values for the different days of treatment, corre-
sponding to the concentration that led to 50% inhibition
of each parameter, were calculated. To determine the
possible toxic effects of the compounds on the host
cells, uninfected macrophages and HMCs were incu-
bated at 37°C with the NQs. After 2 days, the viability of
the cells was measured using the MTT colorimetric
assay [53]. The absorbance was measured at 490 nm
with a spectrophotometer (VERSAmax Tunable, Mo-
lecular Devices, USA), allowing for the determination of
an LC50 value, which is the concentration that reduces
cellular viability by 50%.
Transmission and scanning electron microscopy analysis
Epimastigotes (5×106 cells/mL) were treated for 24 h
with the selected NQs at their respective IC50/24 h
values in LIT medium at 28°C. Afterward, they were
fixed with 2.5% glutaraldehyde in 0.1 M Na-cacodylate
buffer (pH 7.2) for 40 min at 25°C and post-fixed with
1% OsO4, 0.8% potassium ferricyanide and 2.5 mM
CaCl2 in the same buffer for 20 min at 25°C. The cells
were dehydrated in an ascending acetone series and em-
bedded in PolyBed 812 resin. Ultrathin sections were
stained with uranyl acetate and lead citrate and exam-
ined in a Jeol JEM1011 transmission electron micro-
scope (Tokyo, Japan). Alternatively, dehydrated samples
were dried by the critical point method with CO2,
mounted on aluminum stubs, coated with a 20 nm thick
gold layer and examined on a Jeol JSM6390LV scanning
electron microscope (Tokyo, Japan). Both electronmicroscopes are located in Plataforma de Microscopia
Eletrônica at Instituto Oswaldo Cruz (Fiocruz).
Flow cytometry analysis
Epimastigotes were treated for 24 h with the NQs at con-
centrations up to their IC50 values. We then determined
the mitochondrial membrane potential (ΔΨm) and reactive
oxygen species (ROS) production. For ΔΨm analysis, the
parasites were incubated with 50 nM tetramethylrho-
damine (TMRE) (Molecular Probes, Carlsbad, USA) for
15 min at 28°C, using 10 μM carbonyl cyanide 4-
(trifluoromethoxy)phenylhydrazone (FCCP) (Sigma-Aldrich
Chemical Co.) as a control for ΔΨm dissipation. Alter-
ations in TMRE fluorescence were quantified using an
index of variation (IV), which was calculated using the
equation (MT - MC)/MC, where MT is the median of
fluorescence for treated parasites and MC is the median of
fluorescence of the control parasites. Negative IV values
correspond to depolarization of the mitochondrial mem-
brane [54]. To evaluate ROS generation, labeling with
10 μM dihydroethidium (DHE) (Molecular Probes) for
30 min at 28°C was performed, using 22 μM antimycin A
(AA) (Sigma-Aldrich) as the positive control. The samples
were analyzed in a FACSCalibur flow cytometer (Becton
Dickinson, CA, USA) equipped with the Cell Quest
software (Joseph Trotter, Scripps Research Institute, La
Jolla, USA). A total of 10,000 events were acquired in
the region previously established as that of the parasites.
Statistical analysis
The comparison between control and treated groups was
performed using the Mann–Whitney test. Differences
with p ≤ 0.05 were considered statistically significant.
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